Condition: Pulmonary Fibrosis · Lung Cancer · Sponsor: Massachusetts General Hospital
The goal of this study is to investigate the safety of \[68Ga\]CBP8 and its efficacy to detect collagen deposition in pulmonary fibrosis.
This description comes directly from the study's public registry record.
Sydney B Montesi, MD · 617 724 4030 · sbmontesi@partners.org
Abimbola Akinniyi · 781 513 0207 · aakinniyi@mgb.org
Always discuss trial participation with your own doctor first.
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03535545